Axonics (AXNX)
(Real Time Quote from BATS)
$66.82 USD
+0.13 (0.20%)
Updated Apr 29, 2024 02:40 PM ET
2-Buy of 5 2
D Value A Growth C Momentum B VGM
Balance Sheet
Fiscal Year End for Axonics Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 345 | 357 | 221 | 241 | 184 |
Receivables | 57 | 45 | 29 | 18 | 8 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 80 | 56 | 65 | 63 | 16 |
Other Current Assets | 9 | 7 | 6 | 5 | 4 |
Total Current Assets | 491 | 465 | 321 | 328 | 212 |
Net Property & Equipment | 11 | 7 | 7 | 6 | 3 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 181 | 181 | 212 | 0 | 0 |
Deposits & Other Assets | 37 | 7 | 8 | 8 | 5 |
Total Assets | 720 | 659 | 548 | 342 | 220 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 18 | 9 | 8 | 11 | 6 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 21 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 26 | 22 | 18 | 13 | 6 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 33 | 0 | 0 | 0 |
Total Current Liabilities | 46 | 65 | 27 | 46 | 12 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 11 | 16 | 19 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 20 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 10 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 82 | 89 | 66 | 55 | 37 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,034 | 970 | 804 | 522 | 363 |
Retained Earnings | -380 | -374 | -315 | -235 | -180 |
Other Equity | -16 | -25 | -7 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 638 | 570 | 482 | 287 | 183 |
Total Liabilities & Shareholder's Equity | 720 | 659 | 548 | 342 | 220 |
Total Common Equity | 638 | 570 | 482 | 287 | 183 |
Shares Outstanding | 50.60 | 49.50 | 46.30 | 39.80 | 28.60 |
Book Value Per Share | 12.60 | 11.52 | 10.42 | 7.22 | 6.40 |
Fiscal Year End for Axonics Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 345 | 345 | 332 | 357 |
Receivables | NA | 57 | 49 | 47 | 40 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 80 | 75 | 70 | 66 |
Other Current Assets | NA | 9 | 7 | 6 | 6 |
Total Current Assets | NA | 491 | 475 | 455 | 470 |
Net Property & Equipment | NA | 11 | 7 | 6 | 7 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 181 | 176 | 184 | 182 |
Deposits & Other Assets | NA | 37 | 3 | 3 | 7 |
Total Assets | NA | 720 | 661 | 649 | 666 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 18 | 15 | 12 | 15 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 26 | 19 | 18 | 15 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 34 |
Total Current Liabilities | NA | 46 | 36 | 32 | 66 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 11 | 14 | 15 | 16 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 82 | 50 | 48 | 89 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 1,034 | 1,022 | 1,010 | 982 |
Retained Earnings | NA | -380 | -387 | -391 | -384 |
Other Equity | NA | -16 | -25 | -18 | -22 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 638 | 611 | 601 | 577 |
Total Liabilities & Shareholder's Equity | NA | 720 | 661 | 649 | 666 |
Total Common Equity | 0 | 638 | 611 | 601 | 577 |
Shares Outstanding | 51.00 | 50.60 | 50.60 | 50.40 | 50.30 |
Book Value Per Share | 0.00 | 12.60 | 12.07 | 11.92 | 11.46 |